123 Main Street, New York, NY 10001

Top Navigation with Mega Menu
Investor Relations
Changing the Future

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests and that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Learn More

Latest News
Stock Information
Thursday, May 9, 2024
4:30pm - 5:30pm EDT

Co-Dx Q1 2024 Earnings Webcast

Thursday, March 14, 2024
4:30pm - 5:30pm EDT

Co-Dx Q4/FY 2023 Earnings Webcast

All Events

Join Our Newsletter

Receive our latest blog posts directly in your inbox!